H-Index & Metrics Top Publications

H-Index & Metrics

Discipline name H-index Citations Publications World Ranking National Ranking
Immunology H-index 209 Citations 171,417 751 World Ranking 3 National Ranking 2
Medicine H-index 241 Citations 255,978 1,085 World Ranking 15 National Ranking 12

Research.com Recognitions

Awards & Achievements

2019 - AAI-Steinman Award for Human Immunology Research, American Association of Immunologists

2019 - Szent-Györgyi Prize for Progress in Cancer Research, National Foundation for Cancer Research (NFCR)

2018 - Albany Medical Center Prize in Medicine and Biomedical Research

2012 - Keio Medical Science Prize, Keio University, Tokyo, Japan

2010 - Karl Landsteiner Memorial Award, American Association of Blood Banks (AABB)

1987 - Member of the National Academy of Medicine (NAM)

Overview

What is he best known for?

The fields of study he is best known for:

  • Cancer
  • Internal medicine
  • Gene

Immunology, Immunotherapy, Antigen, Melanoma and Adoptive cell transfer are his primary areas of study. His research integrates issues of Cytotoxic T cell and Cancer research in his study of Immunology. His study on Immunotherapy is covered under Cancer.

His research in Antigen focuses on subjects like Molecular biology, which are connected to T-cell receptor. In his work, Gastroenterology and Surgery is strongly intertwined with Internal medicine, which is a subfield of Melanoma. His Interleukin 2 research focuses on Lymphokine-activated killer cell and how it connects with Cell culture.

His most cited work include:

  • Cancer : Principles and Practice of Oncology (8948 citations)
  • Cancer immunotherapy: moving beyond current vaccines. (2543 citations)
  • A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone. (2480 citations)

What are the main themes of his work throughout his whole career to date?

His primary areas of investigation include Immunology, Immunotherapy, Antigen, Melanoma and Cancer research. As a part of the same scientific study, he usually deals with the Immunology, concentrating on Cytotoxic T cell and frequently concerns with CD8. His study in Immunotherapy is interdisciplinary in nature, drawing from both In vivo and Pathology.

Steven A. Rosenberg has researched Antigen in several fields, including Molecular biology, Antibody and T-cell receptor. His Melanoma study integrates concerns from other disciplines, such as Metastasis and Tumor antigen. The study incorporates disciplines such as Gastroenterology, Surgery and Cardiology in addition to Internal medicine.

He most often published in these fields:

  • Immunology (43.33%)
  • Immunotherapy (30.37%)
  • Antigen (26.78%)

What were the highlights of his more recent work (between 2013-2021)?

  • Cancer research (22.48%)
  • Immunology (43.33%)
  • Adoptive cell transfer (19.13%)

In recent papers he was focusing on the following fields of study:

His primary scientific interests are in Cancer research, Immunology, Adoptive cell transfer, Immunotherapy and Cancer. In his study, Mutant is inextricably linked to T cell, which falls within the broad field of Cancer research. He has included themes like Cell, Tumor-infiltrating lymphocytes, T-cell receptor, Minigene and Chimeric antigen receptor in his Adoptive cell transfer study.

His Immunotherapy research includes elements of Cytotoxic T cell and Lung cancer, Oncology. His Cancer research is included under the broader classification of Internal medicine. His Antigen study integrates concerns from other disciplines, such as Receptor, Immune system and Cancer immunotherapy.

Between 2013 and 2021, his most popular works were:

  • T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial (1636 citations)
  • Adoptive cell transfer as personalized immunotherapy for human cancer. (1238 citations)
  • Chemotherapy-Refractory Diffuse Large B-Cell Lymphoma and Indolent B-Cell Malignancies Can Be Effectively Treated With Autologous T Cells Expressing an Anti-CD19 Chimeric Antigen Receptor (1037 citations)

In his most recent research, the most cited papers focused on:

  • Cancer
  • Internal medicine
  • Gene

Steven A. Rosenberg mainly focuses on Immunology, Immunotherapy, Antigen, Adoptive cell transfer and Cancer. His research links Cytotoxic T cell with Immunology. His research in Immunotherapy intersects with topics in Melanoma and Oncology.

His Antigen research is multidisciplinary, incorporating perspectives in Receptor, Cancer research, Cyclophosphamide and Somatic cell. His studies deal with areas such as Minigene, Cancer immunotherapy, MHC class I, T-cell receptor and Interleukin 2 as well as Adoptive cell transfer. The concepts of his Internal medicine study are interwoven with issues in Gastroenterology and Surgery.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Top Publications

Cancer : Principles and Practice of Oncology

Vincent T. DeVita;Samuel Hellman;Steven A. Rosenberg.
(1982)

17227 Citations

A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone.

Steven A. Rosenberg;Michael T. Lotze;Linda M. Muul;Alfred E. Chang.
The New England Journal of Medicine (1987)

3413 Citations

A Randomized Trial of Bevacizumab, an Anti–Vascular Endothelial Growth Factor Antibody, for Metastatic Renal Cancer

James C. Yang;Leah Haworth;Richard M. Sherry;Patrick Hwu.
The New England Journal of Medicine (2003)

3325 Citations

Cancer immunotherapy: moving beyond current vaccines.

Steven A Rosenberg;James C Yang;Nicholas P Restifo.
Nature Medicine (2004)

3230 Citations

Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes

Mark E. Dudley;John R. Wunderlich;Paul F. Robbins;James C. Yang.
Science (2002)

3186 Citations

Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic Cancer

Steven A. Rosenberg;Michael T. Lotze;Linda M. Muul;Susan Leitman.
The New England Journal of Medicine (1985)

3078 Citations

Cancer regression in patients after transfer of genetically engineered lymphocytes

Richard A. Morgan;Mark E. Dudley;John R. Wunderlich;Marybeth S. Hughes.
Science (2006)

3074 Citations

Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.

Elizabeth A Grimm;A. Mazumder;H. Z. Zhang;S. A. Rosenberg.
Journal of Experimental Medicine (1982)

2586 Citations

Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report.

S A Rosenberg;B S Packard;P M Aebersold;D Solomon.
The New England Journal of Medicine (1988)

2578 Citations

A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes

Steven A. Rosenberg;Paul Spiess;Rene Lafreniere.
Science (1986)

2156 Citations

Profile was last updated on December 6th, 2021.
Research.com Ranking is based on data retrieved from the Microsoft Academic Graph (MAG).
The ranking h-index is inferred from publications deemed to belong to the considered discipline.

If you think any of the details on this page are incorrect, let us know.

Contact us

Top Scientists Citing Steven A. Rosenberg

Carl H. June

Carl H. June

University of Pennsylvania

Publications: 238

Jedd D. Wolchok

Jedd D. Wolchok

Memorial Sloan Kettering Cancer Center

Publications: 234

Francesco M. Marincola

Francesco M. Marincola

National Institutes of Health

Publications: 202

Malcolm K. Brenner

Malcolm K. Brenner

Baylor College of Medicine

Publications: 177

Giorgio Parmiani

Giorgio Parmiani

University of Siena

Publications: 177

Nicholas P. Restifo

Nicholas P. Restifo

National Institutes of Health

Publications: 174

Pedro Romero

Pedro Romero

University of Lausanne

Publications: 171

Stanley R. Riddell

Stanley R. Riddell

Fred Hutchinson Cancer Research Center

Publications: 164

David H. Sachs

David H. Sachs

Icahn School of Medicine at Mount Sinai

Publications: 156

Antoni Ribas

Antoni Ribas

University of California, Los Angeles

Publications: 155

John M. Kirkwood

John M. Kirkwood

University of Pittsburgh

Publications: 151

Mark J. Smyth

Mark J. Smyth

QIMR Berghofer Medical Research Institute

Publications: 148

Alexander M.M. Eggermont

Alexander M.M. Eggermont

Erasmus University Rotterdam

Publications: 147

Daniel E. Speiser

Daniel E. Speiser

University of Lausanne

Publications: 145

Philip D. Greenberg

Philip D. Greenberg

Fred Hutchinson Cancer Research Center

Publications: 145

Something went wrong. Please try again later.